Question special

Congratulations again to the authors for their great work demonstrating olaparib response on the basis of molecular stratification in patients with metastatic prostate cancer. Thank you to everyone who participated for sharing their insights and for a lively discussion this week. I am certain we will hear more about the authors' breakthrough research on this topic in the near future.

As our discussion comes to a close, If there are any final thoughts, please feel free to share.